Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Next Previous
Trial Profile

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 17 Nov 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oesophageal stem cell implant (Primary)
  • Indications Oesophageal cancer; Oesophageal disorders; Oesophageal perforation
  • Focus Adverse reactions; First in man; Therapeutic Use
  • Sponsors Harvard Apparatus Regenerative Technology

    • Most Recent Events

    • 13 Nov 2023 According to a Biostage media release, the company has activated the second clinical trial site with the University of Michigan in August 2023 to expand the screening of patients and actively recruiting clinical trial patients at both the Mayo Clinic and University of Michigan.
    • 18 Jul 2023 Status changed from not yet recruiting to recruiting, according to a Biostage media release.
    • 18 Jul 2023 According to a Biostage media release, the company has activated the site with Mayo Clinic in this study.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top